Table of Contents Table of Contents
Previous Page  103 / 252 Next Page
Information
Show Menu
Previous Page 103 / 252 Next Page
Page Background

101

BUSINESS SECTORS

years, as well as import duties. The air and water

quality in Brunei are suitable to grow microalgae.

Brunei offers among the lowest utility rates in

the region.

MC Biotech’s BND20 million production facility

is called the ‘Sinar Suria Bio Center’. In Malay,

‘Sinar Suria’ means ‘sunlight’, a testament to MC

Biotech’s desire for eco-friendly growth methods

using natural means, and the needs of the

haematococcus algae in producing astaxanthin.

The facility aims to be one of the top suppliers

of quality astaxanthin. Sinar Suria Bio Centre

is the first commercial biotechnology facility at

the Bio-Innovation Corridor, an industrial park

geared to attract Halal and bio-industry related

investments.

Executive Director Yuki Kaneda said MC Biotech

Sdn Bhd was formed as a result of putting forth

a proposal of cultivating astaxanthin-producing

microalgae in Brunei. A collaborative research

effort was carried out with the government. MC

Biotech successfully cultivated the microalgae

and extracted astaxanthin. Based on the results,

a promising future lies ahead to develop the culti-

vation of microalgae and related-biotechnological

industries due to Brunei’s naturally purer air and

water, and cleaner environment which positively

affects the growth of the microalgae.

MC Biotech received support from DARe, a

statutory body that has helped many local

startups. DARe assisted MC Biotech with

networking and logistics. MC Biotech announced

they would transition to the commercial phase in

the DARe Bio Innovation Corridor.

In September 2017, MC Biotech participated in

the 7th Vitafoods Asia Event in Singapore. The

company joined more than 200 global suppliers

in the nutraceutical industry to showcase their

latest products and innovations.

One of the challenges MC Biotech faces is

the amount of time and discussions needed to

proceed with commercialisation. To assist MC

Biotech, the Brunei government has given them

permits and licenses to begin operations.

MC Biotech uses their commercially proven

Japanese technology. As part of their

procedures, they must have an astaxanthin

concentration of more than four per cent. To

increase the astaxanthin concentration, MC

Biotech will continue their research. They

have found local strains of the algae isolated

in Brunei. Some of them produced astaxanthin.

As such, these strains may be potentially

used for commercial purposes. MC Biotech

will conduct further research on the optimal

conditions needed to produce astaxanthin.

Microalgae cultivation technology is not limited

to astaxanthin production. Microalgae is a

potential source for food and fuel. MC Biotech

aims to expand its horizon beyond health

supplements and cosmetic products.